Usefulness of optical enhancement endoscopy combined with magnification to improve detection of intestinal metaplasia in the stomach

Abstract

Background and study aims The light blue crest observed in narrow band imaging endoscopy has high diagnostic accuracy for diagnosis of gastric intestinal metaplasia (GIM). The objective of this prospective study was to evaluate the diagnostic accuracy of magnifying i-scan optical enhancement (OE) imaging for diagnosing the LBC sign in patients with different levels of risk for gastric cancer in a Mexican clinical practice.

Patients and methods Patients with a history of peptic ulcer and symptoms of dyspepsia or gastroesophageal reflux disease were enrolled. Diagnosis of GIM was made at the predetermined anatomical location and white light endoscopy and i-scan OE Mode 1 were captured at the two predetermined biopsy sites (antrum and pyloric regions).

Results A total of 328 patients were enrolled in this study. Overall GIM prevalence was 33.8 %. The GIM distribution was 95.4 % in the antrum and 40.5 % in the corpus. According to the Operative Link on Gastritis/Intestinal-Metaplasia Assessment staging system, only two patients (1.9 %) were classified with high-risk stage disease. Sensitivity, specificity, positive​ and negative predictive values, positive and negative likelihood ratios, and accuracy of both methods (95 % C. I.) were 0.50 (0.41–0.60), 0.55 (0.48–0.62), 0.36 (0.31–0.42), 0.68 (0.63–0.73), 1.12 (0.9–1.4), 0.9 (0.7–1.1), and 0.53 (0.43–0.60) for WLE, and 0.96 (0.90–0.99), 0.91 (0.86–0.94), 0.84 (0.78–0.89), 0.98 (0.94–0.99), 10.4 (6.8–16), 0.05 (0.02–0.12), and 0.93 (0.89–0.95), respectively. The kappa concordance was 0.67 and the reliability coefficient was 0.7407 for interobserver variability.

Conclusions Our study demonstrated the high performance of magnifying i-scan OE imaging for endoscopic diagnosis of GIM in Mexican patients.

Publication History

Received: 14 July 2021

Accepted after revision: 11 January 2022

Article published online:
14 April 2022

• References

• 1 Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis 2012; 13: 2-9
• 2 Leung WK, Sung JJ. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther 2002; 16: 1209-1216
• 3 Dinis-Ribeiro M, Areia M, de Vries AC. et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94
• 4 Veitch AM, Uedo N, Yao K. Optimizing early upper gastrointestinal cancer detection at endoscopy. Nat Rev Gastroenterol Hepatol 2015; 12: 660-667
• 5 Uedo N, Ishihara R, Yamamoto S. et al. A new method of diagnosing gastric intestinal metaplasia: narrow−band imaging with magnifying endoscopy. Endoscopy 2006; 38: 819-824
• 6 An JK, Song GA, Kim GH. et al. Marginal turbid band and light blue crest, signs observed in magnifying narrow-band imaging endoscopy, are indicative of gastric intestinal metaplasia. BMC Gastroenterol 2012; 12: 169
• 7 Pimentel-Nunes P, Libânio D, Lage J. et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy 2016; 48: 723-30
• 8 Wang L, Huang W, Du J. et al. Diagnostic yield of the light blue crest sign in gastric intestinal metaplasia: a meta-analysis. PLoS One 2014; 9: e92874
• 9 Neumann H, Fujishiro M, Wilcox CM. et al. Present and future perspectives of virtual chromoendoscopy with i-scan and optical enhancement technology. Digest Endosc 2014; 26: 43-51
• 10 Verna C, Feyles E, Lorenzi L. et al. I-SCAN targeted versus random biopsies in Barrett's oesophagus. Dig Liver Dis 2014; 46: 131-134
• 11 Sobrino-Cossío S, Abdo-Francis JM, Mateos-Pérez G. et al. Efficacy of narrow-band imaging for detecting intestinal metaplasia in adult patients with symptoms of dyspepsia. Rev Gastroenterol Méx 2018; 83: 245-252
• 12 Dixon MF, Genta RM, Yardley JH. et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
• 13 Saka A, Yagi K, Nimura S. OLGA- and OLGIM-based staging of gastritis using narrow-band imaging magnifying endoscopy. Dig Endosc 2015; 27: 734-741
• 14 Fukuta N, Ida K, Kato T. et al. Study Group for Investigating Endoscopic Diagnosis of Gastric Intestinal Metaplasia. Endoscopic diagnosis of gastric intestinal metaplasia: A prospective multicenter study. Digest Endosc 2013; 25: 526-534
• 15 Rugge M, Cappellesso R, Kuipers EJ. Precancerous lesions in the stomach: From biology to clinical patient management. Best Practice & Research Clinical Gastroenterology 2013; 27: 205-223
• 16 Capelle LG, de Vries AC, Haringsma J. et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010; 71: 1150-1158
• 17 Anonymous. Live flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, 7–14 June 1994. IARC Monogr. Eval Carcinog Risks Hum 1994; 61: 1-241
• 18 Fock KM, Talley N, Moayyedi P. et al. Asia-Pacific Gastric Cancer Consensus Conference. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008; 23: 351-365
• 19 Watabe H, Mitsushima T, Yamaji Y. et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005; 54: 764-768
• 20 de Vries AC, van Grieken NC, Looman CW. et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134: 945-952
• 21 Song H, Ekheden IG, Zheng Z. et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ 2015; 351: h3867
• 22 Whiting JL, Sigurdsson A, Rowlands DC. et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002; 50: 378-381
• 23 Yokoyama I. Clinical study on endoscopic diagnosis of intestinal metaplasia. Gastroenterolog Endosc 1975; 17: 65-75
• 24 Kaminishi M, Yamaguchi H, Nomura S. et al. Endoscopic classification of chronic gastritis based on a pilot study by the Research Society for Gastritis. Dig Endosc 2002; 14: 138-151
• 25 Nagata N, Shimbo T, Akiyama J. et al. Predictability of gastric intestinal metaplasia by mottled patchy erythema seen on endoscopy. Gastroenterol Res 2011; 4: 203-209
• 26 Yip HC, Uedo N, Chan SM. et al. An international survey on recognition and characterization of atrophic gastritis and intestinal metaplasia. Endosc Int Open 2020; 8: E1365-E1370
• 27 Bansal A, Ulusarac O, Mathur S. et al. Correlation between narrow band imaging and nonneoplastic gastric pathology: A pilot feasibility trial. Gastrointest Endosc 2008; 67: 210-216
• 28 Bai AD, Showler A, Burry L. et al. Clinical prediction rules in Staphylococcus aureus bacteremia demonstrate the usefulness of reporting likelihood ratios in infectious diseases. Eur J Clin Microbiol Infect Dis 2016; 35: 1393-1398
• 29 Singh R, Lee SY, Vijay N. et al. Update on narrow band imaging in disorders of the upper gastrointestinal tract. Digestive Endoscopy 2014; 26: 144-153
• 30 Kanzaki H, Uedo N, Ishihara R. et al. Comprehensive investigation of areae gastricae pattern in gastric corpus using magnifying narrow band imaging endoscopy in patients with chronic atrophic fundic gastritis. Helicobacter 2012; 17: 224-231
• 31 Kanemitsu T, Yao K, Nagahama T. et al. Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker. Endoscopy 2017; 49: 529-535
• 32 Lee JS, Jeon SW, Kwon YH. Comparative Study of narrow-band imaging and i-scan for predicting the histology of intermediate-to-large colorectal polyps: a prospective, randomized pilot study. Clin Endosc 2021; 54: 881-887